Variant report
Variant | nsv603134 |
---|---|
Chromosome Location | chr6:54841672-54851340 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs368607711 | chr6:54845003-54845004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs570049032 | chr6:54845016-54845017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536149499 | chr6:54845033-54845034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs148679549 | chr6:54845034-54845035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555390857 | chr6:54845054-54845055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563465040 | chr6:54845066-54845067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs534823158 | chr6:54845077-54845078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557905778 | chr6:54845117-54845118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577740726 | chr6:54845124-54845125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs543634319 | chr6:54845141-54845142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs36030916 | chr6:54845145-54845146 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs370757489 | chr6:54845165-54845166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574028856 | chr6:54845210-54845211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs556819005 | chr6:54845240-54845241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs62416541 | chr6:54845284-54845285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186147942 | chr6:54845295-54845296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532688218 | chr6:54845312-54845313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs544801359 | chr6:54845313-54845314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs191120664 | chr6:54845339-54845340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs576856076 | chr6:54845341-54845342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533348475 | chr6:54845351-54845352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs151187594 | chr6:54845361-54845362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs141304638 | chr6:54845374-54845375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529550825 | chr6:54845387-54845388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs143731755 | chr6:54845395-54845396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs7752353 | chr6:54845396-54845397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535045588 | chr6:54845434-54845435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557951827 | chr6:54845473-54845474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10948879 | chr6:54845489-54845490 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs536849078 | chr6:54845533-54845534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs35619856 | chr6:54845563-54845564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs557195659 | chr6:54845571-54845572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs368696649 | chr6:54845581-54845582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs573942905 | chr6:54845643-54845644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs372328762 | chr6:54845654-54845655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565497836 | chr6:54845656-54845657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs113273956 | chr6:54845691-54845692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542959932 | chr6:54845694-54845695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552977086 | chr6:54845722-54845723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs140559421 | chr6:54845798-54845799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs183383818 | chr6:54845811-54845812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564822228 | chr6:54845823-54845824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374842405 | chr6:54845828-54845829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs188370168 | chr6:54845853-54845854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543564910 | chr6:54845858-54845859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs563554176 | chr6:54845893-54845894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs112422311 | chr6:54845910-54845911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs192323004 | chr6:54845911-54845912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs143957381 | chr6:54845926-54845927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs540957169 | chr6:54845952-54845953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Neurocytoma | 17123091 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Neuroblastoma | 19686582 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:54845000-54847000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
2 | chr6:54845400-54846000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr6:54845400-54846600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr6:54845400-54847200 | Enhancers | HMEC | breast |
5 | chr6:54845400-54847200 | Enhancers | NHEK | skin |
6 | chr6:54845600-54846200 | Enhancers | Hela-S3 | cervix |
7 | chr6:54845600-54846800 | Enhancers | Muscle Satellite Cultured Cells | -- |
8 | chr6:54845600-54846800 | Enhancers | NHLF | lung |
9 | chr6:54845600-54847000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr6:54845800-54847000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
11 | chr6:54845800-54847000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr6:54846000-54846400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
13 | chr6:54846400-54846800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
14 | chr6:54846400-54847000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr6:54846600-54847000 | Flanking Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
16 | chr6:54847000-54847400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
17 | chr6:54847000-54854800 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
18 | chr6:54847000-54856800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
19 | chr6:54847200-54847600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
20 | chr6:54847200-54847600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
21 | chr6:54847600-54848000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
22 | chr6:54847600-54848200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |